Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer

Clinical Cancer Research

Volumn 15, Issue 20, 2009, Pages 6348-6357

  Mandapathil, Magis ^a,d   Szczepanski, Miroslaw J ^a   Szajnik, Marta ^a   Ren, Jin ^b   Lenzner, Diana E ^c   Jackson, Edwin K ^b   Gorelik, Elieser ^a   Lang, Stephan ^d   Johnson, Jonas T ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5' NUCLEOTIDASE; ADENOSINE; ADENOSINE TRIPHOSPHATE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; ECTONUCLEOTIDASE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER STAGING; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; ADULT; AGED; ANTIGENS, CD; APYRASE; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; N-GLYCOSYL HYDROLASES; T-LYMPHOCYTES, REGULATORY;

EID: 70350231926     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1143     Document Type: Article

References (50)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Fremgen AM, Bland KI, McGinnis LS, Jr., et al. Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin 1999;49:145-158
3. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345: 1890-1900
4. Benchetrit F, Gazagne A, Adotevi O, et al. Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy. Bull Cancer 2003;90: 677-685 (Pubitemid 37239070)
5. Toes RE, Ossendorp F, Offringa R, Melief CJ. CD4 T cells and their role in antitumor immune response. J Exp Med 1999;189:753-756 (Pubitemid 29189679)
6. high regulatory cells in peripheral blood of cancer patients. Neuroendocrinol Lett 2008;29: 240-245
7. Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9: 606-612 (Pubitemid 36182591)
8. + T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007;13:6301-6311
9. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-1294 (Pubitemid 32524778)
10. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-1310 (Pubitemid 32524780)
11. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-742 (Pubitemid 27458961)
12. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001;182:68-79.
13. Wada J, Yamasaki A, Nagai S, et al. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. Anticancer Res 2008;28:2401-2408
14. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204: 1257-1265 (Pubitemid 46919862)
15. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007;110:1225-1232
16. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006;177:6780-6786 (Pubitemid 44715042)
17. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-920 (Pubitemid 34024743)
18. Panther ES, Corinti M, Idzko YH. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003;101:3985-3990
19. Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 2005; 26:299-304.
20. Lokshin A, Raskovalova T, Huang X, Zacharia LC, Jackson EK, Gorelik E. Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells. Cancer Res 2006;66:7758-7765 (Pubitemid 44289236)
21. + regulatory T cells cultured with rapamycin. J Immunol 2007;178:320-329
22. Jackson SW, Hoshi T, Wu Y, et al. Disordered purinergic signaling inhibits pathological angiogenesis in CD39/Entpd1-null mice. Am J Pathol 2007;171:1395-1404 (Pubitemid 47582911)
23. Ohta AE, Gorelik SJ, Prasad F. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 2006;103:13132-13137
24. + regulatory T cells in small cell lung cancer reflects disease stage. Clin Cancer Res 2008;14:6770-6779
25. Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforine are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 2007;27:635-646 (Pubitemid 47628832)
26. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 2008;14: 5947-5952
27. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells. Int J Oncol 2008;32:527-535 (Pubitemid 351330458)
28. Buffon A, Wink MR, Ribeiro BV. NTPDase and 5′ ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor. Biochim Biophys Acta 2007;1770:1259-1265
29. Yamada T, Okajima F, Akbar M. Cell cycle arrest and the induction of apoptosis in pancreatic cancer cells exposed to adenosine triphosphate in vitro. Oncol Rep 2002;9:113-117
30. Höpfner M, Maaser K, Barthel B. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Colorectal Dis 2001; 16:154-166
31. Janssens R, Boeynaems JM. Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 2001;132: 536-546 (Pubitemid 32142367)
32. Wang MX, Ren LM, Shan BE. Inhibitory effects of extracellular adenosine triphosphate on growth of esophageal carcinoma cells. World J Gastroenterol 2005;11:5915-5919 (Pubitemid 41749201)
33. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997;90:1600-1610 (Pubitemid 27355433)
34. Bouma MG, Jeunhomme TM, Boyle DL, et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol 1997;158:5400-5408
35. 2) release by activated human neutrophils. Clin Immunol Immunopathol 1987;42:76-85.
36. MacKenzie WM, Hoskin DW, Blay J. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res 1994;54: 3521-3526 (Pubitemid 24225977)
37. Barcz E, Sommer E, Sokolnicka I, et al. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. Oncol Rep 1998;5: 517-520 (Pubitemid 28100124)
38. Ethier MF, Chander V, Dobson JG, Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 1993;265: H131-8. (Pubitemid 23224700)
39. Pueyo ME, Chen Y, D'Angelo G, Michel JB. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp Cell Res 1998;238:354-358 (Pubitemid 28372822)
40. Grant MB, Tarnuzzer RW, Caballero S. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 1999;85: 699-706. (Pubitemid 29480810)
41. Eigler A, Greten TF, Sinha B, Haslberger C, Sullivan GW, Endres S. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol 1997;45:132-139 (Pubitemid 27047241)
42. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J Immunol 1996;156: 3435-3442 (Pubitemid 26124449)
43. Szabó C, Scott GS, Virág L, et al. Suppression of macrophage inflammatory protein (MIP)-1α production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998;125:379-387 (Pubitemid 28425204)
44. Kittel A, Garrido M, Varga G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. J Histochem Cytochem 2002;50: 549-556 (Pubitemid 34250594)
45. Dzhandzhugazyan KN, Kirkin AF, thor Straten P, Zeuthen J. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett 1998;430:227-230
46. Spychala J, Lazarowski E, Ostapkowicz A, Ayscue LH, Jin A, Mitchell BS. Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clin Cancer Res 2004;10:708-717 (Pubitemid 38174010)
47. Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 1997;57:2602-2605 (Pubitemid 27283766)
48. 2a receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 2008;111: 251-259
49. Whiteside TL. Immunobiology of head and neck cancer. Cancer Metastasis Rev 2005;24: 95-105.
50. Duarte MM, Loro VL, Rocha JB, et al. Enzymes that hydrolyze adenine nucleotides of patients with hypercholesterolemia and inflammatory processes. FEBS J 2007;274: 2707-2714